+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vaccine Development"

Avian Influenza Vaccine Market in United States - Product Thumbnail Image

Avian Influenza Vaccine Market in United States

  • Report
  • February 2026
  • 190 Pages
  • United States
From
Rotavirus Vaccine Market in United States - Product Thumbnail Image

Rotavirus Vaccine Market in United States

  • Report
  • December 2025
  • 150 Pages
  • United States
From
Tetanus Toxoid Vaccine Market in United States - Product Thumbnail Image

Tetanus Toxoid Vaccine Market in United States

  • Report
  • December 2025
  • 150 Pages
  • United States
From
Measles Vaccine Market in United States - Product Thumbnail Image

Measles Vaccine Market in United States

  • Report
  • December 2025
  • 150 Pages
  • United States
From
From
Influenza Vaccines Market Report 2023-2033 - Product Thumbnail Image

Influenza Vaccines Market Report 2023-2033

  • Report
  • October 2023
  • 192 Pages
  • Global
From
Anti-infective Vaccines Market Report 2023-2033 - Product Thumbnail Image

Anti-infective Vaccines Market Report 2023-2033

  • Report
  • September 2023
  • 303 Pages
  • Global
From
From
From
Influenza Market - Vaccines and Therapeutics - Product Thumbnail Image

Influenza Market - Vaccines and Therapeutics

  • Report
  • April 2025
  • 387 Pages
  • Global
From
Loading Indicator

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise. The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more